Skip to main content
NVDA+1.02%AAPL-0.11%GOOGL+0.86%MSFT+0.95%AMZN+0.90%TSM+2.75%SPCX+7.63%META+0.12%AVGO+2.08%TSLA+0.74%SKHY-0.06%MU+0.34%BRK-B+0.32%LLY+0.02%AMD-0.34%JPM0.00%WMT+0.78%ASMLa+0.37%V+2.51%XOM+0.01%JNJ-1.21%INTC-2.63%0700.HK+1.23%MA+2.23%ABBV+1.12%1398.HK+1.61%CSCO+0.55%LRCX-0.49%AP2d+1.10%AMAT+0.41%CVX-0.11%ORCL+0.18%COST+0.31%CAT+0.32%BAC+0.47%KO+1.00%DELL-1.86%PG+0.71%UNH+1.80%0005.HK+1.93%HSBA.L+0.74%3988.HK+1.69%ARM-1.49%1816.HK+0.48%GE-1.04%0857.HK+1.04%MS-0.06%0939.HK+1.47%PM+1.10%1288.HK+0.92%PLNJPY+0.80%USDMXN-0.73%USDZAR-0.71%AUDCHF+0.71%USDPLN-0.68%AUDJPY+0.59%CHFSEK-0.53%USDSEK-0.52%GBPCHF+0.49%NZDMXN-0.42%GBPTRY+0.41%GBPJPY+0.40%NOKJPY+0.39%EURZAR-0.38%AUDUSD+0.37%EURPLN-0.35%EURHKD+0.34%GBPZAR-0.34%AUDNZD+0.33%EURAUD-0.32%GBPHKD+0.32%USDDKK-0.32%CADCHF+0.31%AUDCAD+0.30%NZDCHF+0.30%EURCNH+0.30%EURCHF+0.29%GBPMXN-0.28%CHFNOK-0.27%USDNOK-0.26%USDCHF+0.26%SGDJPY+0.25%GBPUSD+0.23%GBPSGD+0.23%CADJPY+0.22%NZDJPY+0.22%EURJPY+0.20%GBPNZD+0.19%EURSGD+0.19%EURSEK-0.19%EURGBP-0.19%USDJPY+0.19%AUDDKK-0.18%GBPCAD+0.18%NZDSGD+0.18%EURCZK-0.17%GBPAUD-0.17%USDILS+0.16%USDTHB+0.16%CHFSGD-0.15%AUDNOK-0.13%USDSGD-0.13%USDTRY+0.11%CHFJPY-0.09%EURNOK+0.07%USDCAD-0.04%EURUSD+0.04%USDCOP-0.04%NZDUSD+0.04%USDCNH-0.03%EURCAD-0.01%EURDKK+0.01%EURNZD+0.01%USDHKD+0.01%NZDCAD-0.01%AUDSGD0.00%UKOIL-2.95%USOIL-2.11%COCOA-1.99%XPTUSD-1.18%GAUUSD+0.72%XAUUSD+0.72%XNGUSD+0.51%XAGUSD+0.37%GAGUSD+0.37%HG1-0.19%COFFEE+0.18%COTTON+0.12%BTCUSD+0.50%ETHUSD+6.15%USDTUSD-0.03%XRPUSD-0.54%SOLUSD-2.00%TRXUSDT-0.18%ZECUSDT+2.47%DOGEUSD-1.82%XMRUSDT-0.35%LINKUSD+3.21%XLMUSD+0.06%BCHUSDT+0.03%UNIUSD-2.06%LTCUSD-4.60%SUIUSD-1.70%HBARUSDT-0.81%TONUSD+12.52%TAOUSDT-0.98%AAVEUSD+0.42%DOTUSDT-1.19%ICPUSDT-4.40%ONDOUSDT-0.40%WLDUSDT+1.36%ARBUSDT-3.49%JUPUSDT-1.57%ATOMUSDT-0.97%INJUSDT+2.01%STXUSDT-0.18%FETUSDT-2.01%SEIUSDT-0.61%PYTHUSDT+1.77%TIAUSDT-0.59%IMXUSDT-2.28%GRTUSDT-1.14%OPUSDT-3.71%IOTAUSDT+3.73%WIFUSDT0.00%AXSUSDT-1.25%POLUSDT-0.37%FARTCOINUSDT+1.67%EOSUSDT+5.57%DYDXUSDT-2.60%GALAUSDT-0.92%ORDIUSDT+1.85%RONINUSDT+2.94%NOTUSDT+1.29%NVDA+1.02%AAPL-0.11%GOOGL+0.86%MSFT+0.95%AMZN+0.90%TSM+2.75%SPCX+7.63%META+0.12%AVGO+2.08%TSLA+0.74%SKHY-0.06%MU+0.34%BRK-B+0.32%LLY+0.02%AMD-0.34%JPM0.00%WMT+0.78%ASMLa+0.37%V+2.51%XOM+0.01%JNJ-1.21%INTC-2.63%0700.HK+1.23%MA+2.23%ABBV+1.12%1398.HK+1.61%CSCO+0.55%LRCX-0.49%AP2d+1.10%AMAT+0.41%CVX-0.11%ORCL+0.18%COST+0.31%CAT+0.32%BAC+0.47%KO+1.00%DELL-1.86%PG+0.71%UNH+1.80%0005.HK+1.93%HSBA.L+0.74%3988.HK+1.69%ARM-1.49%1816.HK+0.48%GE-1.04%0857.HK+1.04%MS-0.06%0939.HK+1.47%PM+1.10%1288.HK+0.92%PLNJPY+0.80%USDMXN-0.73%USDZAR-0.71%AUDCHF+0.71%USDPLN-0.68%AUDJPY+0.59%CHFSEK-0.53%USDSEK-0.52%GBPCHF+0.49%NZDMXN-0.42%GBPTRY+0.41%GBPJPY+0.40%NOKJPY+0.39%EURZAR-0.38%AUDUSD+0.37%EURPLN-0.35%EURHKD+0.34%GBPZAR-0.34%AUDNZD+0.33%EURAUD-0.32%GBPHKD+0.32%USDDKK-0.32%CADCHF+0.31%AUDCAD+0.30%NZDCHF+0.30%EURCNH+0.30%EURCHF+0.29%GBPMXN-0.28%CHFNOK-0.27%USDNOK-0.26%USDCHF+0.26%SGDJPY+0.25%GBPUSD+0.23%GBPSGD+0.23%CADJPY+0.22%NZDJPY+0.22%EURJPY+0.20%GBPNZD+0.19%EURSGD+0.19%EURSEK-0.19%EURGBP-0.19%USDJPY+0.19%AUDDKK-0.18%GBPCAD+0.18%NZDSGD+0.18%EURCZK-0.17%GBPAUD-0.17%USDILS+0.16%USDTHB+0.16%CHFSGD-0.15%AUDNOK-0.13%USDSGD-0.13%USDTRY+0.11%CHFJPY-0.09%EURNOK+0.07%USDCAD-0.04%EURUSD+0.04%USDCOP-0.04%NZDUSD+0.04%USDCNH-0.03%EURCAD-0.01%EURDKK+0.01%EURNZD+0.01%USDHKD+0.01%NZDCAD-0.01%AUDSGD0.00%UKOIL-2.95%USOIL-2.11%COCOA-1.99%XPTUSD-1.18%GAUUSD+0.72%XAUUSD+0.72%XNGUSD+0.51%XAGUSD+0.37%GAGUSD+0.37%HG1-0.19%COFFEE+0.18%COTTON+0.12%BTCUSD+0.50%ETHUSD+6.15%USDTUSD-0.03%XRPUSD-0.54%SOLUSD-2.00%TRXUSDT-0.18%ZECUSDT+2.47%DOGEUSD-1.82%XMRUSDT-0.35%LINKUSD+3.21%XLMUSD+0.06%BCHUSDT+0.03%UNIUSD-2.06%LTCUSD-4.60%SUIUSD-1.70%HBARUSDT-0.81%TONUSD+12.52%TAOUSDT-0.98%AAVEUSD+0.42%DOTUSDT-1.19%ICPUSDT-4.40%ONDOUSDT-0.40%WLDUSDT+1.36%ARBUSDT-3.49%JUPUSDT-1.57%ATOMUSDT-0.97%INJUSDT+2.01%STXUSDT-0.18%FETUSDT-2.01%SEIUSDT-0.61%PYTHUSDT+1.77%TIAUSDT-0.59%IMXUSDT-2.28%GRTUSDT-1.14%OPUSDT-3.71%IOTAUSDT+3.73%WIFUSDT0.00%AXSUSDT-1.25%POLUSDT-0.37%FARTCOINUSDT+1.67%EOSUSDT+5.57%DYDXUSDT-2.60%GALAUSDT-0.92%ORDIUSDT+1.85%RONINUSDT+2.94%NOTUSDT+1.29%
XP

Xenon Pharmaceuticals Inc. (XENE)

NASDAQ • Healthcare

$37.57
-$0.45 (-1.2%)
Market closed

Last close at October 5, 2026 at 20:00 UTC

Open$38.02
Day Range$37 - $38.23
Avg. Volume (3M)2.7M
Market Cap$3.6B
52 Week Range
$36.07$72.66
Next EarningsIn 27 daysNov 2, 2026

Metrics Over Time

Fundamentals & Financials

Revenue (TTM)
$0
Net Income (TTM)
-$409.1M
EPS (TTM)
-$4.74
ROA (TTM)
-31.58%
Current Ratio
21.02

TTM is calculated as the sum of the four most recently completed quarters. This is a standard approach when monthly or real-time data is not available.

Earnings

-9.2%Q1 2026-$1.31
0.0%Q2 2026-$1.17
+2.6%Q3 2026-$1.11
Next

Nov 2

in 27 daysQ4 2026

% — EPS deviation from the forecast (beat / miss); quarters without a forecast show the reported EPS

Latest report — Q3 2026
Beat +2.6%

Xenon Pharmaceuticals topped the EPS estimate in the second fiscal quarter of 2026, reported on August 6, based on preliminary results, with EPS of $-1.11 against a $-1.14 estimate, +2.6%. The company said net income was a loss of about $110.7 million, down 30.7% from a loss of $84.7 million a year ago, while EPS improved to $-1.11 from $-1.07 a year earlier, a 3.7% decline. Operating income came in at about negative $123.2 million, and operating cash flow was negative $95.4 million. Consensus for the next period calls for EPS of $-1.17 on revenue of $1.3 million.

Next report — what to expect

Xenon Pharmaceuticals Inc. (XENE) reports next on November 2, 2026. Wall Street is looking for consensus EPS of -$1.17 on revenue of $1.3 million. Traders will be watching how results compare with those targets, with XENE having beaten EPS in 5 of its 8 most recent quarters.

View full earnings history

About Xenon Pharmaceuticals Inc.

Xenon Pharmaceuticals Inc. develops ion channel-targeted medicines for neurological disorders as a clinical-stage biotechnology company listed on the NASDAQ Global Market under ticker XENE. Founded in 1996 and based in Burnaby, British Columbia, Xenon centers its pipeline on experimental therapies for epilepsy, developmental and epileptic encephalopathies, and pain.

Name
Xenon Pharmaceuticals Inc.
CEO
Ian C. Mortimer
Website
www.xenon-pharma.com
Industry
Healthcare
Year Founded
1996
Employees
364

Today's Snapshot

AI-generated

Yesterday XENE fell 1.2% to 37.57. Xenon Pharmaceuticals granted 28,350 stock awards to new hires.

Trading Volume

Below 10d avg (2.6M)

1.6M

vs S&P 500 Today

Underperforming Market

-1.84%

Updated: October 6, 2026 at 12:20 UTC

Technical Indicators

2 Buy0 Neutral6 Sell
Xenetic shows a pronounced bearish picture with price well below its short, medium and long moving averages and a strongly negative MACD, while ADX indicates a firm trending move to the downside. Short-term oscillators are deeply oversold but momentum remains negative, ATR points to elevated volatility, and on-balance volume is negative, reinforcing selling pressure. The pivot sits slightly above the market and offers little relief. Technical takeaway: Strong Sell.
All signals
  • EMA (5 indicators)$39.62 - $54.43
    Sell
  • RSI (14)23.72
    Buy
  • Stochastic %K (14, 3, 3)9.26
    Buy
  • MACD Level (12, 26)-6.04
    Sell

Peers & Related Assets

APGEApogee Therapeutics, Inc.
$135.07-0.0%
CGONCG Oncology Inc.
$68.71+2.0%
TVTXTravere Therapeutics, Inc.
$57.67+1.3%
SRRKScholar Rock Holding Corporation
$43.4-7.3%
CELCCelcuity Inc.
$73.62+2.1%
RAREUltragenyx Pharmaceutical Inc.
$14.5-4.7%
Stay Ahead of the Market

Get premium market insights delivered directly to your inbox.